BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16937846)

  • 21. Activity level and process indicators of organised programmes for cervical cancer screening in Italy.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2006; 30(1 Suppl 3):27-40. PubMed ID: 16937844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
    Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of cervical intraepithelial neoplasia on the cervix in Chinese women: pooled analysis of 19 population based screening studies.
    Zhao YQ; Chang IJ; Zhao FH; Hu SY; Smith JS; Zhang X; Li SM; Bai P; Zhang WH; Qiao YL
    BMC Cancer; 2015 Jun; 15():485. PubMed ID: 26122004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological discrepancy between colposcopic directed cervical biopsy and Loop Electrosurgical-Excision Procedures (LEEPs) in patients with biopsies proven high grade cervical intraepithelial neoplasia.
    Noothong S; Inthasorn P; Warnnissorn M
    Taiwan J Obstet Gynecol; 2017 Oct; 56(5):628-631. PubMed ID: 29037548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'See and treat' electrosurgical loop excision of the cervical transformation zone.
    Ferris DG; Hainer BL; Pfenninger JL; Zuber TJ
    J Fam Pract; 1996 Mar; 42(3):253-7. PubMed ID: 8636676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3.
    Yang HP; Zuna RE; Schiffman M; Walker JL; Sherman ME; Landrum LM; Moxley K; Gold MA; Dunn ST; Allen RA; Zhang R; Long R; Wang SS; Wentzensen N
    PLoS One; 2012; 7(1):e29051. PubMed ID: 22253702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2009; 33(3 Suppl 2):41-56. PubMed ID: 19776486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrepancy between colposcopy, punch biopsy and final histology of cone specimen: a prospective study.
    Petousis S; Christidis P; Margioula-Siarkou C; Sparangis N; Athanasiadis A; Kalogiannidis I
    Arch Gynecol Obstet; 2018 May; 297(5):1271-1275. PubMed ID: 29442140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative management of CIN2: National Audit of British Society for Colposcopy and Cervical Pathology members' opinion.
    Macdonald M; Smith JHF; Tidy JA; Palmer JE
    J Obstet Gynaecol; 2018 Apr; 38(3):388-394. PubMed ID: 29212399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of colposcopy with dynamic spectral imaging for cytology-negative/high-risk HPV positive (failed test of cure) after large loop excision of the transformation zone (LLETZ) of the cervix: Results of the DySIS colposcopy 1 study.
    Founta C; Papagiannakis E; Ratnavelu N; Feusi A; Natsis S; Bradbury M; Fisher A; Naik R
    Medicine (Baltimore); 2018 Jan; 97(1):e9560. PubMed ID: 29505536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
    Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
    BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying the risk of cervical intraepithelial neoplasia in women with unsatisfactory colposcopy results.
    Massad LS; Tate N; Cejtin E; Collins YC
    J Low Genit Tract Dis; 2005 Jan; 9(1):23-8. PubMed ID: 15870518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyto-colpo-histologic correlation: about an analytical study of 120 colposcopies.
    Slimani O; Ben Temim R; Makhlouf T; Mathlouthi N; Attia L
    Tunis Med; 2016 Oct; 94(10):616-620. PubMed ID: 28972254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Findings and outcome of teenage women referred for colposcopy at Christchurch Women's Hospital, New Zealand.
    Sykes P; Harker D; Peddie D
    N Z Med J; 2005 Mar; 118(1211):U1350. PubMed ID: 15778751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 Years.
    Silver MI; Gage JC; Schiffman M; Fetterman B; Poitras NE; Lorey T; Cheung LC; Katki HA; Locke A; Kinney WK; Castle PE
    Cancer Prev Res (Phila); 2018 Mar; 11(3):165-170. PubMed ID: 29437696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up after treatment of high-grade cervical dysplasia: The utility of six-month colposcopy and cytology and routine 12-month colposcopy.
    Morton R; Mylvaganam G; Anderson L; Farrell R; Carter J; Pather S; Saidi S
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):959-964. PubMed ID: 32935336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are Women with Antecedent Low-Grade Cytology and <CIN2 Findings in Colposcopy Being Overmanaged?
    Piedmonte S; Tsang K; Jembere N; Murphy J; McCurdy B; Sacco J; Kupets R
    J Obstet Gynaecol Can; 2022 Oct; 44(10):1054-1060. PubMed ID: 35948169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cancer registry in the monitoring of cervical screening practice: the neglected value of the Pap smear in patients diagnosed with CIN3 on biopsy.
    Serafini M; Bucchi L; Falcini F; Cordaro C; Montanari E; Amadori A; Amadori D
    Eur J Cancer Prev; 1998 Feb; 7(1):45-9. PubMed ID: 9511850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.